Surveillance of adverse drug reactions at an adverse drug reaction monitoring centre in Central India: a 7-year surveillance study

被引:6
|
作者
Sharma, Megha [1 ,2 ]
Baghel, Ruchi [2 ]
Thakur, Sunil [2 ]
Adwal, Sandeep [3 ]
机构
[1] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden
[2] RD Gardi Med Coll, Dept Pharmacol, Ujjain, India
[3] Zydus Med Coll & Hosp, Dept Pharmacol, Dahod, Gujarat, India
来源
BMJ OPEN | 2021年 / 11卷 / 10期
关键词
clinical pharmacology; health & safety; risk management; adverse events; toxicity; pharmacology; PHARMACOVIGILANCE; INPATIENTS; MEDICINE;
D O I
10.1136/bmjopen-2021-052737
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To analyse and present the occurrence and severity of spontaneous adverse drug reaction (ADR) reports prospectively registered at an ADR monitoring centre (AMC) in Central India. Setting and data The survey was conducted between 2013 and 2019 at an ADR Monitoring Centre in Central India. ADRs were recorded using the standard 'Suspected ADR Reporting form'. Outcome measures The causality of the ADRs were categorised using the WHO causality assessment scale to assess the relationship between a drug and the occurrence of an ADR. Results Totally 1980 spontaneous ADRs were reported involving 960 patients and 1316 drugs prescriptions. The occurrence of ADRs was common among male patients (64%) and patients of age between 19 and 65 years (81%). Antimicrobials caused 29% ADRs, followed by drugs of antiretroviral therapy (19%). Zidovudine caused most ADRs (88%) followed by ethambutol and ciprofloxacin. The ADRs of skin and subcutaneous tissue disorders (28%) were most common among all system organ classes followed by gastrointestinal systems (18%). Four per cent of all reported ADRs were severe. A peak of ADR reports was attained in 2016 with 224 reports, which decreased to 127 in 2019. Conclusion A high number of ADRs caused by antimicrobials is an alarming situation, which adds up to antimicrobial resistance. Judicious use of antimicrobials is yet again proven as need of the hour. Under-reporting of ADRs is evident in our study and is a major factor for the delay in the withdrawal of drugs responsible for causing ADRs. Interventions in terms of training and feedback are suggested to encourage and improve ADR reporting.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] SURVEILLANCE OF DRUG ADVERSE REACTIONS
    CAMPBELL, JS
    HENDERSON, IW
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1972, 106 (12) : 1285 - +
  • [2] DRUG SURVEILLANCE FOR ADVERSE REACTIONS
    ANELLO, C
    HANSON, C
    [J]. FDA PAPERS, 1971, 5 (02): : 6 - &
  • [3] SURVEILLANCE OF DRUG ADVERSE REACTIONS
    不详
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1972, 106 (05) : 535 - +
  • [4] ADVERSE DRUG REACTION SURVEILLANCE
    不详
    [J]. HOSPITAL FORMULARY, 1985, 20 (04): : 516 - 516
  • [5] MONITORING OF ADVERSE DRUG REACTIONS: A 7-YEAR STUDY AMONG SWISS PHARMACOVIGILANCE CENTRES
    Ceschi, A.
    Curkovic, I.
    Damke, B.
    Carter, R. Sift
    Rauber-Luethy, C.
    Kupferschmidt, H.
    Russmann, S.
    Kullak-Ublick, G. A.
    Huber, M.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 16 - 16
  • [6] ADVERSE REACTIONS TO DRUGS AND DRUG SURVEILLANCE
    LAPORTE, JR
    [J]. MEDICINA CLINICA, 1989, 92 (14): : 536 - 538
  • [7] ADVERSE DRUG REACTIONS - CONCEPT AND METHODS FOR DRUG SURVEILLANCE
    NARANJO, CA
    MARDONES, J
    [J]. REVISTA MEDICA DE CHILE, 1972, 100 (09) : 1105 - &
  • [8] ADVERSE DRUG-REACTIONS MONITORING - THE CHOICE OF A DRUG SURVEILLANCE METHODS IN TERATOLOGY
    GOUJARD, J
    [J]. THERAPIE, 1985, 40 (05): : 287 - 292
  • [9] A STUDY OF ADVERSE REACTION ALGORITHMS IN A DRUG SURVEILLANCE PROGRAM
    LOUIK, C
    LACOUTURE, PG
    MITCHELL, AA
    KAUFFMAN, R
    LOVEJOY, FH
    YAFFE, SJ
    SHAPIRO, S
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (02) : 183 - 187
  • [10] ADVERSE DRUG REACTION REPORTING IN A MULTICENTER SURVEILLANCE STUDY
    TIMM, EG
    WELAGE, LS
    WALAWANDER, CA
    SAYERS, JFB
    KARPIUK, EL
    DAVIS, TD
    GRASELA, TH
    [J]. ANNALS OF PHARMACOTHERAPY, 1995, 29 (03) : 240 - 245